Identification |
Name: | Inosine,6-S-[(4-nitrophenyl)methyl]-6-thio- |
Synonyms: | 6-[(4-Nitrobenzyl)thio]-9-b-D-ribofuranosylpurine; NBMPR;NSC 296962; S-(4-Nitrobenzyl)-6-thioinosine; S-(p-Nitrobenzyl)-6-mercapto-9-b-D-ribofuranosylpurine |
CAS: | 38048-32-7 |
EINECS: | 253-753-4 |
Molecular Formula: | C17H17 N5 O6 S |
Molecular Weight: | 419.41 |
InChI: | InChI=1/C17H17N5O6S/c23-5-11-13(24)14(25)17(28-11)21-8-20-12-15(21)18-7-19-16(12)29-6-9-1-3-10(4-2-9)22(26)27/h1-4,7-8,11,13-14,17,23-25H,5-6H2/t11-,13-,14-,17-/m1/s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 187-190 °C(lit.)
|
Flash Point: | 419.6°C |
Boiling Point: | 770.2°Cat760mmHg |
Density: | 1.78g/cm3 |
Refractive index: | 1.807 |
Biological Activity: | Equilibrative nucleoside transporter 1 (ENT1) inhibitor (K i values are 0.4 and 2800 nM for hENT1 and hENT2 respectively). |
Flash Point: | 419.6°C |
Storage Temperature: | 2-8°C |
Color: | white |
Usage: | It is a prototype inhibitor of the human equilibrative nucleoside transporter (hENT1), and is a high affinity ligand with a Kd of 0.1-1.0 nM. Nucleoside transporter inhibitors have potential therapeutic applications as anticancer, antiviral, cardio |
Safety Data |
|
|